Sign in
4

Changes in Ownership

Alkermes plc. Filed Acc 0001127602-21-013891

EVP R&D, Chief Medical Officer sold 28,920 shares at $19.72 ($570,288)

From the SEC's structured data for this filing

Trades in this filing

Hopkinson Craig C. · EVP R&D, Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-04-15 Sale : show line 1 in the form −28,920 $19.72 $570,288 0 D
Open-market sales · 28,920 sh · avg $19.72 · $570,288
Loading xslF345X03/form4.xml…